Bendamustine hydrochloride and Colitis - pseudomembranous - a phase IV clinical study of FDA data
Summary:
Colitis - pseudomembranous is reported as a side effect among people who take Bendamustine hydrochloride (bendamustine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Melphalan, and have Burkitt lymphoma.
The phase IV clinical study analyzes which people have Colitis - pseudomembranous when taking Bendamustine hydrochloride. It is created by eHealthMe based on reports of 9,160 people who have side effects when taking Bendamustine hydrochloride from the FDA, and is updated regularly.
What is Bendamustine hydrochloride?
Bendamustine hydrochloride has active ingredients of bendamustine hydrochloride. eHealthMe is studying from 9,169 Bendamustine hydrochloride users. Check the latest studies of Bendamustine hydrochloride.
What is Colitis - pseudomembranous?
Colitis - pseudomembranous (severe acute inflammation of the bowel mucosa, with the formation of pseudomembranous plaques; it is usually associated with antimicrobial therapy) is found to be associated with 800 drugs and 933 conditions by eHealthMe. Check the latest studies of Colitis - pseudomembranous.
9,160 people reported to have side effects when taking Bendamustine hydrochloride.
Among them, 15 people (0.16%) have Colitis - pseudomembranous.

Among these 15 people:
How long have people been on Bendamustine hydrochloride when they have Colitis - pseudomembranous? *
- < 1 month: 20 %
- 1 - 6 months: 80 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Colitis - pseudomembranous when taking Bendamustine hydrochloride? *
- female: 92.86 %
- male: 7.14 %
What is the age of people who have Colitis - pseudomembranous when taking Bendamustine hydrochloride? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
What are other drugs people take besides Bendamustine hydrochloride? *
- Thalidomide: 5 people, 33.33%
- Lenalidomide: 5 people, 33.33%
- Bortezomib: 5 people, 33.33%
- Carfilzomib: 5 people, 33.33%
- Darzalex: 5 people, 33.33%
- Dexamethasone: 5 people, 33.33%
- Etoposide: 5 people, 33.33%
- Kyprolis: 5 people, 33.33%
- Melphalan: 5 people, 33.33%
- Polaramine: 4 people, 26.67%
What are other side effects people have besides Colitis - pseudomembranous? *
- Cytomegalovirus Infection: 8 people, 53.33%
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 7 people, 46.67%
- Cerebral Toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii): 5 people, 33.33%
- Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 5 people, 33.33%
- Colitis (inflammation of colon): 5 people, 33.33%
- Multiple Myeloma (cancer of the plasma cells): 5 people, 33.33%
- Lymphopenia (an abnormally low level of lymphocytes in the blood): 5 people, 33.33%
- Renal Impairment (severely reduced kidney function): 5 people, 33.33%
- Klebsiella Sepsis (klebsiella causes a potentially fatal whole-body inflammation): 4 people, 26.67%
- High Blood Pressure: 4 people, 26.67%
What are the existing conditions these people have? *
- Burkitt Lymphoma (cancer of the lymphatic system): 6 people, 40.00%
- Multiple Myeloma (cancer of the plasma cells): 5 people, 33.33%
- Intracranial Pressure Increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid): 5 people, 33.33%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 6.67%
- Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 6.67%
- Diffuse Large B-Cell Lymphoma Refractory (cancer of b cells, a type of white blood cell-relapsed): 1 person, 6.67%
- Diffuse Large B-Cell Lymphoma Recurrent (recurrent cancer of b cells, a type of white blood cell): 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Bendamustine hydrochloride and have Colitis - pseudomembranous?
- Check whether Colitis - pseudomembranous is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Bendamustine hydrochloride:
- Bendamustine hydrochloride (9,169 reports)
Colitis - pseudomembranous treatments and more:
- Colitis - pseudomembranous (3,347 reports)
How severe was Colitis - pseudomembranous and when was it recovered:
Expand to all the drugs that have ingredients of bendamustine hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Bendamustine hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Colitis - pseudomembranous:
- Colitis - pseudomembranous (800 drugs)
Browse all the conditions that are associated with Colitis - pseudomembranous:
- Colitis - pseudomembranous (933 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on bendamustine hydrochloride (the active ingredients of Bendamustine hydrochloride) and Bendamustine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lantus Solostar cause Decreased Activity? - 4 seconds ago
- Could Lotrel cause Gout? - 28 seconds ago
- Drug interactions of Guaifenesin and Seroquel - 32 seconds ago
- Could Lortab cause Viral Infection? - 38 seconds ago
- Incontinence and Lip Dry - 41 seconds ago
- Drug interactions of Adenosine and Magnesium - 54 seconds ago
- Could Acetaminophen And Codeine Phosphate cause Fainting? - 54 seconds ago
- Could Fasenra cause Chills? - a minute ago
- Could Zide cause Acute Myocardial Infarction? - a minute ago
- Could Gliclazide cause Drug Ineffective? - a minute ago